Sign in
WithdrawnNo phase

Evaluation of Neurosteer System in Stroke Patients

Key facts

Who runs it
Neurosteer Ltd.
Where
Israel1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
1 Jan 2023
Ended
31 Dec 2023
Type of study
Observational
Treatments tested
  • Neurosteer EEG recorder
Record updated
8 March 2024
Why it stopped
No patients were recruited by the hospital staff

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Men and women over the age of 18
  • Hospitalized in Soroka University Medical Center (SUMC) Neurology department with a diagnosis of Stroke
  • NIHSS score ≥6

Who cannot take part

  • Damage to integrity of scalp and/or skull
  • Any verbal or non-verbal form of objection from patient
  • Any verbal or non-verbal form of objection from patient's family member or significant other

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through a series of EEG recordings during their hospitalization. EEG recordings will be analyzed using proprietary computational analyses.

The group in the trial

  • Patients

    Patients who are hospitalized in Soroka University Medical Center (SUMC) Neurology department with a diagnosis of acute stroke

    Treatment: Neurosteer EEG recorder

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of Neurosteer System (Quantitative EEG Features) in Stroke Patients Suffering From Disorders of Consciousness
Record updated
8 March 2024